Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients
Amazingly, almost 50 years after the first demonstration of anticancer effects of cannabinoids in vitro and in vivo, well-designed clinical trials that definitively prove tumour-inhibiting effects in man are still missing. Whereas a large number of preclinical studies exist that describe tumour-inhi...
Main Author: | Gerhard Nahler |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-12-01
|
Series: | Exploration of Medicine |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/em/Article/1001182 |
Similar Items
-
Phytocannabinoids: Pharmacological effects, biomedical applications, and worldwide prospection
by: Ana L.G. de Brito Siqueira, et al.
Published: (2023-11-01) -
Chemical profiling of Cannabis sativa from eleven Tanzanian regions
by: Husna B. Mhando, et al.
Published: (2023-05-01) -
Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population
by: Santiago Gómez Velásquez, et al.
Published: (2023-03-01) -
Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01) -
Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015
by: Albert Stuart Reece, et al.
Published: (2022-01-01)